Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
about
The role of genetic polymorphisms in environmental health.Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression.Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.Pharmacogenetics of asthma.CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction.The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women.Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.Identification of a novel splice-site mutation in the CYP1A2 geneCoffee, caffeine-related genes, and Parkinson's disease: a case-control studyRapid genotyping for relevant CYP1A2 alleles by pyrosequencing.Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Factors affecting interindividual differences in clozapine response: a review and case report.Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among EmiratisPolymorphisms of cytochrome p450 genes in three ethnic groups from Russia.Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism.The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism.Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.Individual differences in in vitro and in vivo metabolic clearances of antipsychotic risperidone from Japanese subjects genotyped for cytochrome P450 2D6 and 3A5.Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3.Effects of CYP1A2 gene polymorphisms on antipyrine CYP1A2-dependent metabolism.Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans.
P2860
Q24815139-A05FCB1A-3213-4746-ACAB-457E53B570FEQ33828034-1E51993B-B74F-42C7-9E3C-A238DBD8A091Q34142068-EBF3943C-3E5C-4CF5-A5D8-93F41A4A3C35Q34311814-1652910C-077C-4DAC-A327-55241E402C22Q34534425-3E1C59B5-EDDE-44E2-8D53-0AEA470DC715Q34699532-6FB3B7C3-BF1B-400D-B966-C4A6E0ABD576Q35015993-2AAB0168-E38B-4EA7-8D88-BEDCB3997FC3Q35443937-B86D02B7-7609-41B0-AE68-D8248234723DQ35804103-219C0524-3517-413A-A17D-CF650A735675Q35804108-B9B48BBC-BD8C-4670-B514-F933745875ADQ35825664-5D939BC8-6143-408F-967A-9EF79A8D771CQ36011013-70EF3493-E314-493F-AAFD-418BE57B2940Q36321854-FA9EB0BC-BE7F-4A6C-B5F9-5EF1588A58D7Q36365599-CEB813EA-9535-4AD2-B55A-C0D6D908BC52Q36807462-D744ACAC-85AA-48B3-85C1-566AC8F8D35BQ37157901-64DCDD67-8256-46CD-8132-8E44F14C0EF4Q37378059-EBBDC8B2-62DB-4718-BC4E-21FE373C63AFQ37715233-EBD9A61A-AB51-4D7C-B148-D48330B1372BQ37860249-27209D4C-5805-4597-BCA1-C25F2E825A5CQ38103885-39A3DEB9-B883-445B-B3BA-AE4B6CC06A10Q39042845-A66CE5C7-D082-49FD-B18F-3A84783F29ABQ41730140-291E3B83-BB49-4625-B58F-28E15D812D50Q41908761-EEF63783-C77D-490F-8461-606DA1149691Q42152085-DEC17D2B-C00B-4323-852F-C34C0FFFB3F9Q42284296-48FBCDE1-D406-4C31-9783-A8C85F1FC1BBQ42994051-98E6FA48-11FF-4F23-89D3-DC578F3E36EBQ44038091-B9303DF0-49CE-40D4-B748-D05616583199Q45915624-448C70B6-DA0C-416B-AAD2-BD26DC7AEA54Q46007459-91699B21-AA8A-4E86-8F53-63086B4631DFQ46118627-5B844197-7CCB-4836-8D0F-468C7F6CACBEQ46359082-FB82E78A-EC13-4404-A497-EDDF1AAE8998Q46587398-37036171-CE4C-4996-A8FC-E101CC3EA18CQ46872878-E0A990CE-355C-4420-9D9D-97B537BAF239Q46928365-2D988EE1-8A42-4E50-808E-2132A1523D4FQ47224986-3000BFF1-1D2A-4075-8177-21D79DF381E5Q47881455-E51C011B-F653-4DFA-88DD-B23D93539836Q50933157-1D4B7A9F-CF2F-44A8-9D2F-EEE456EF5FCFQ50933183-40F39491-BAAE-44B7-9982-7AB86F506742Q51567684-FC33C38D-EA35-41E5-B513-3C93F2038923Q53594370-6D22F1EC-D30C-48DA-8F36-52D3592FD4EE
P2860
Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Detection of three genetic pol ...... A2 in the Japanese population.
@en
Detection of three genetic pol ...... A2 in the Japanese population.
@nl
type
label
Detection of three genetic pol ...... A2 in the Japanese population.
@en
Detection of three genetic pol ...... A2 in the Japanese population.
@nl
prefLabel
Detection of three genetic pol ...... A2 in the Japanese population.
@en
Detection of three genetic pol ...... A2 in the Japanese population.
@nl
P2093
P2860
P1476
Detection of three genetic pol ...... A2 in the Japanese population.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1999.TB00832.X
P577
1999-09-01T00:00:00Z